Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$2.73 - $3.7 $54,600 - $74,000
20,000 New
20,000 $58,000
Q1 2022

May 09, 2022

BUY
$3.58 - $4.98 $71,600 - $99,600
20,000 New
20,000 $84,000
Q4 2021

Feb 09, 2022

SELL
$4.17 - $7.09 $83,400 - $141,800
-20,000 Closed
0 $0
Q3 2020

Nov 05, 2020

SELL
$11.33 - $19.81 $67,980 - $118,859
-6,000 Reduced 23.08%
20,000 $372,000
Q4 2019

Feb 04, 2020

BUY
$5.74 - $7.42 $149,240 - $192,920
26,000 New
26,000 $191,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.57B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Tobias Financial Advisors, Inc. Portfolio

Follow Tobias Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobias Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tobias Financial Advisors, Inc. with notifications on news.